Genetics of Risk-Taking Behavior: Current Knowledge, Challenges and Future Directions
نویسندگان
چکیده
منابع مشابه
Genetics of Recurrent Miscarriage: Challenges, Current Knowledge, Future Directions
Recurrent miscarriage (RM) occurs in 1-3% of couples aiming at childbirth. Due to multifactorial etiology the clinical diagnosis of RM varies. The design of genetic/"omics" studies to identify genes and biological mechanisms involved in pathogenesis of RM has challenges as there are several options in defining the study subjects (female patient and/or couple with miscarriages, fetus/placenta) a...
متن کاملCurrent Knowledge, Challenges, and Future Directions
The most common cause of peripheral arterial disease (PAD) is atherosclerotic vascular disease. PAD because of atherosclerosis is relatively highly prevalent, affecting >200 million people worldwide, including an estimated 8 to 10 million individuals in the United States alone. Atherosclerotic PAD is typically identified in the clinical setting when patients present with claudication or critica...
متن کاملImpact of Financial Characteristics on Future Corporate Risk-Taking Behavior
Organizational risk is often defined as a change in the flow of profit, or as a sys-tematic or non-systematic changes in the stock return flow. The risk taking of management is conceptualized as the actual investment decisions that are indictors due to uncertainty results. The purpose of this study is to investigate the effect of financial characteristics on future corporate risk taking behavio...
متن کاملUltrasonography: current status, challenges, and future directions
Since Ultrasonography was launched as an international peer-reviewed academic journal dedicated to medical ultrasound (US) in January 2014, it has been an honor and privilege for me to serve as the journal’s Honorary Editor [1]. The purpose of this editorial update is to provide readers with some recent information and to share my views on the journal and its future directions. During the last ...
متن کاملAlcoholic hepatitis: current challenges and future directions.
Alcoholic hepatitis is a distinct clinical syndrome among people with chronic and active alcohol abuse, with a potential for 30%-40% mortality at 1 month among those with severe disease. Corticosteroids or pentoxifylline are the current pharmacologic treatment options, but they provide only about 50% survival benefit. These agents are recommended for patients with modified discriminant function...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Yaşar University
سال: 2021
ISSN: 1305-970X
DOI: 10.19168/jyasar.826953